Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Makoto Tahara | Researchclopedia

Back to researchers

Makoto Tahara

National Cancer Center Hospital East ORCID

599

Works

30,107

Citations

62

h-index

248

i10-index

Research Topics

Head and Neck Cancer Studies Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers

Affiliations

University of Pisa2023–2023

Oklahoma State University1991–1991

Tokyo University of Agriculture1992–1992

Novartis (Switzerland)2022–2022

Fox Chase Cancer Center2016–2016

Top Works

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Robert L. Ferris,George R. Blumenschein,et al.

20164,974 citations

Thyroid Cancer Diagnosis and Treatment

Head and Neck Surgical Oncology

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness,Kevin J. Harrington,et al.

20193,093 citations

Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer

Martin Schlumberger,Makoto Tahara,et al.

20152,025 citations

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials

David S. Hong,Steven G. DuBois,et al.

2020964 citations

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort

Laura Q.M. Chow,Robert I. Haddad,et al.

2016850 citations

Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

Robert L. Ferris,George R. Blumenschein,et al.

2018787 citations

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Nancy Y. Lee,Robert L. Ferris,et al.

2021590 citations

Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study

Kevin J. Harrington,Barbara Burtness,et al.

2022453 citations

Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012

Ranee Mehra,Tanguy Y. Seiwert,et al.

2018447 citations